Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes

Immunology

Volumn 140, Issue 4, 2013, Pages 475-482

  Montalvo, Vanessa ^a   Quigley, Laura ^b   Vistica, Barbara P ^a   Boelte, Kimberly C ^b   Nugent, Lindsey F ^a   Takai, Toshiyuki ^c   Mcvicar, Daniel W ^b   Gery, Igal ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Cytokines; Lymphoid cells; Ocular inflammation; TREM 2

Indexed keywords

INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE UVEITIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DAP12 PROTEIN DEFICIENCY; ENVIRONMENTAL FACTOR; IMMUNOPATHOGENESIS; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

CYTOKINES; LYMPHOID CELLS; OCULAR INFLAMMATION; TREM-2;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENVIRONMENT; EYE; EYE PROTEINS; HOUSING, ANIMAL; INFLAMMATION MEDIATORS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RETINOL-BINDING PROTEINS; UVEITIS;

EID: 84886625121     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12158     Document Type: Article

References (37)

1. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998; 391:703-7.
2. Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 2005; 6:579-86.
3. Tomasello E, Vivier E. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol 2005; 35:1670-7.
4. Turnbull IR, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol 2007; 7:155-61.
5. Hu X, Chen J, Wang L, Ivashkiv LB. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol 2007; 82:237-43.
6. Chu CL, Yu YL, Shen KY, Lowell CA, Lanier LL, Hamerman JA. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRγ. Eur J Immunol 2008; 38:166-73.
7. Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 2009; 227:150-60.
8. McVicar DW, Taylor LS, Gosselin P et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem 1998; 273:32934-42.
9. Hamerman JA, Ni M, Killebrew JR, Chu CL, Lowell CA. The expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells. Immunol Rev 2009; 232:42-58.
10. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164:4991-5.
11. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410:1103-7.
12. Gibot S, Kolopp-Sarda MN, Bene MC, Bollaert PE, Lozniewski A, Mory F, Levy B, Faure GC. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004; 200:1419-26.
13. Turnbull IR, McDunn JE, Takai T, Townsend RR, Cobb JP, Colonna M. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J Exp Med 2005; 202:363-9.
14. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201:647-57.
15. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006; 177:2051-5.
16. Divangahi M, Yang T, Kugathasan K et al. Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J Immunol 2007; 179:4015-26.
17. Bakker AB, Hoek RM, Cerwenka A et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 2000; 13:345-53.
18. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007; 37:1290-301.
19. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 2007; 4:e124.
20. + Treg in the absence of a functional DAP12 adaptor protein. Eur J Immunol 2008; 38:3191-9.
21. Gery I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and immunopathogenic processes they provoke. Prog Retinal Res 1986; 5:75-109.
22. Nussenblatt RB, Gery I. Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease. J Autoimmun 1996; 9:575-85.
23. Caspi RR. Ocular autoimmunity: the price of privilege? Immunol Rev 2006; 213:23-35.
24. Kaifu T, Nakahara J, Inui M et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 2003; 111:323-32.
25. Lai JC, Wawrousek EF, Sipe JD, Whitecup SM, Gery I. Reduced susceptibility to IL-1 and endotoxin in transgenic mice expressing IL-1 in their lens. Cytokine 1996; 8:288-93.
26. Takase H, Yu CR, Liu X, Fujimoto C, Gery I, Egwuagu CE. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J Neuroimmunol 2005; 168:118-27.
27. Chan CC, Caspi RR, Ni M, Leake WC, Wiggert B, Chader GJ, Nussenblatt RB. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun 1990; 3:247-55.
28. Avichezer D, Silver PB, Chan CC, Wiggert B, Caspi RR. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci 2000; 41:127-31.
29. Fujimoto C, Klinman DM, Shi G et al. A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin Exp Immunol 2009; 156:528-34.
30. Luger D, Silver PB, Tang J et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008; 205:799-810.
31. Gandhi R, Laron A, Weiner HL. Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 2010; 221:7-14.
32. Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010; 10:501-13.
33. Whittaker GC, Orr SJ, Quigley L, Hughes L, Francischetti IM, Zhang W, McVicar DW. The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells. J Biol Chem 2010; 285:2976-85.
34. Weber B, Saurer L, Schenk M, Dickgreber N, Mueller C. CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions. Eur J Immunol 2011; 41:773-9.
35. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010; 28:623-67.
36. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol 2012; 30:759-95.
37. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159-69.